Literature DB >> 31006619

A Chemical Strategy for Protease Substrate Profiling.

Andrew R Griswold1, Paolo Cifani2, Sahana D Rao3, Abram J Axelrod4, Matthew M Miele5, Ronald C Hendrickson5, Alex Kentsis6, Daniel A Bachovchin7.   

Abstract

The dipeptidyl peptidases (DPPs) regulate hormones, cytokines, and neuropeptides by cleaving dipeptides after proline from their amino termini. Due to technical challenges, many DPP substrates remain unknown. Here, we introduce a simple method, termed CHOPS (chemical enrichment of protease substrates), for the discovery of protease substrates. CHOPS exploits a 2-pyridinecarboxaldehyde (2PCA)-biotin probe, which selectively biotinylates protein N-termini except those with proline in the second position. CHOPS can, in theory, discover substrates for any protease, but is particularly well suited to discover canonical DPP substrates, as cleaved but not intact DPP substrates can be identified by gel electrophoresis or mass spectrometry. Using CHOPS, we show that DPP8 and DPP9, enzymes that control the Nlrp1 inflammasome through an unknown mechanism, do not directly cleave Nlrp1. We further show that DPP9 robustly cleaves short peptides but not full-length proteins. More generally, this work delineates a practical technology for identifying protease substrates, which we anticipate will complement available "N-terminomic" approaches.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  N-terminal modification; Nlrp1 inflammasome; chemical probes; mass spectrometry-based proteomics; protease substrates

Mesh:

Substances:

Year:  2019        PMID: 31006619      PMCID: PMC6588500          DOI: 10.1016/j.chembiol.2019.03.007

Source DB:  PubMed          Journal:  Cell Chem Biol        ISSN: 2451-9448            Impact factor:   8.116


  45 in total

1.  WebLogo: a sequence logo generator.

Authors:  Gavin E Crooks; Gary Hon; John-Marc Chandonia; Steven E Brenner
Journal:  Genome Res       Date:  2004-06       Impact factor: 9.043

2.  Crystal structure of human dipeptidyl peptidase IV/CD26 in complex with a substrate analog.

Authors:  Hanne B Rasmussen; Sven Branner; Finn C Wiberg; Nicolai Wagtmann
Journal:  Nat Struct Biol       Date:  2003-01

3.  Validation and development of fluorescence two-dimensional differential gel electrophoresis proteomics technology.

Authors:  R Tonge; J Shaw; B Middleton; R Rowlinson; S Rayner; J Young; F Pognan; E Hawkins; I Currie; M Davison
Journal:  Proteomics       Date:  2001-03       Impact factor: 3.984

4.  Structural basis of IAP recognition by Smac/DIABLO.

Authors:  G Wu; J Chai; T L Suber; J W Wu; C Du; X Wang; Y Shi
Journal:  Nature       Date:  2000 Dec 21-28       Impact factor: 49.962

5.  Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition.

Authors:  C Du; M Fang; Y Li; L Li; X Wang
Journal:  Cell       Date:  2000-07-07       Impact factor: 41.582

Review 6.  Dipeptidyl peptidase IV activity and/or structure homologues (DASH) and their substrates in cancer.

Authors:  Petr Busek; Radek Malík; Aleksi Sedo
Journal:  Int J Biochem Cell Biol       Date:  2004-03       Impact factor: 5.085

Review 7.  Prolyl peptidases: a serine protease subfamily with high potential for drug discovery.

Authors:  Jonathan S Rosenblum; John W Kozarich
Journal:  Curr Opin Chem Biol       Date:  2003-08       Impact factor: 8.822

8.  PT-100, a small molecule dipeptidyl peptidase inhibitor, has potent antitumor effects and augments antibody-mediated cytotoxicity via a novel immune mechanism.

Authors:  Sharlene Adams; Glenn T Miller; Michael I Jesson; Takeshi Watanabe; Barry Jones; Barbara P Wallner
Journal:  Cancer Res       Date:  2004-08-01       Impact factor: 12.701

9.  N-terminal His(7)-modification of glucagon-like peptide-1(7-36) amide generates dipeptidyl peptidase IV-stable analogues with potent antihyperglycaemic activity.

Authors:  B D Green; M H Mooney; V A Gault; N Irwin; C J Bailey; P Harriott; B Greer; F P M O'Harte; P R Flatt
Journal:  J Endocrinol       Date:  2004-03       Impact factor: 4.286

10.  Inhibition of food intake in obese subjects by peptide YY3-36.

Authors:  Rachel L Batterham; Mark A Cohen; Sandra M Ellis; Carel W Le Roux; Dominic J Withers; Gary S Frost; Mohammad A Ghatei; Stephen R Bloom
Journal:  N Engl J Med       Date:  2003-09-04       Impact factor: 91.245

View more
  12 in total

1.  Mapping proteolytic neo-N termini at the surface of living cells.

Authors:  Amy M Weeks; James R Byrnes; Irene Lui; James A Wells
Journal:  Proc Natl Acad Sci U S A       Date:  2021-02-23       Impact factor: 11.205

Review 2.  The NLRP1 inflammasome: new mechanistic insights and unresolved mysteries.

Authors:  Patrick S Mitchell; Andrew Sandstrom; Russell E Vance
Journal:  Curr Opin Immunol       Date:  2019-05-20       Impact factor: 7.486

3.  Mapping Cell Surface Proteolysis with Plasma Membrane-Targeted Subtiligase.

Authors:  Aspasia A Amiridis; Amy M Weeks
Journal:  Methods Mol Biol       Date:  2022

4.  Deorphanizing Caspase-3 and Caspase-9 Substrates In and Out of Apoptosis with Deep Substrate Profiling.

Authors:  Luam E Araya; Ishankumar V Soni; Jeanne A Hardy; Olivier Julien
Journal:  ACS Chem Biol       Date:  2021-09-23       Impact factor: 4.634

5.  M24B aminopeptidase inhibitors selectively activate the CARD8 inflammasome.

Authors:  Sahana D Rao; Qifeng Chen; Qinghui Wang; Elizabeth L Orth-He; Michelle Saoi; Andrew R Griswold; Abir Bhattacharjee; Daniel P Ball; Hsin-Che Huang; Ashley J Chui; Dominic J Covelli; Shaochen You; Justin R Cross; Daniel A Bachovchin
Journal:  Nat Chem Biol       Date:  2022-02-14       Impact factor: 16.174

6.  DPP9 sequesters the C terminus of NLRP1 to repress inflammasome activation.

Authors:  L Robert Hollingsworth; Humayun Sharif; Andrew R Griswold; Pietro Fontana; Julian Mintseris; Kevin B Dagbay; Joao A Paulo; Steven P Gygi; Daniel A Bachovchin; Hao Wu
Journal:  Nature       Date:  2021-03-17       Impact factor: 49.962

7.  Dipeptidyl peptidase 9 sets a threshold for CARD8 inflammasome formation by sequestering its active C-terminal fragment.

Authors:  Humayun Sharif; L Robert Hollingsworth; Andrew R Griswold; Jeffrey C Hsiao; Qinghui Wang; Daniel A Bachovchin; Hao Wu
Journal:  Immunity       Date:  2021-05-20       Impact factor: 43.474

8.  DPP8/9 inhibitors are universal activators of functional NLRP1 alleles.

Authors:  Kuo Gai; Marian C Okondo; Sahana D Rao; Ashley J Chui; Daniel P Ball; Darren C Johnson; Daniel A Bachovchin
Journal:  Cell Death Dis       Date:  2019-08-05       Impact factor: 8.469

Review 9.  End-Binding E3 Ubiquitin Ligases Enable Protease Signaling.

Authors:  Matthew Ravalin; Koli Basu; Jason E Gestwicki; Charles S Craik
Journal:  ACS Chem Biol       Date:  2019-11-20       Impact factor: 4.634

10.  DPP9's Enzymatic Activity and Not Its Binding to CARD8 Inhibits Inflammasome Activation.

Authors:  Andrew R Griswold; Daniel P Ball; Abir Bhattacharjee; Ashley J Chui; Sahana D Rao; Cornelius Y Taabazuing; Daniel A Bachovchin
Journal:  ACS Chem Biol       Date:  2019-09-20       Impact factor: 5.100

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.